4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-048239
Chief Financial Officer bought 17,200 shares at an average $2.55 ($43,913)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-08-30 | Purchase | +7,200 | $2.55 | $18,341 | 272,952 | D |
| Byam Rebecca Chief Financial Officer | 2022-08-31 | Purchase | +10,000 | $2.56 | $25,572 | 282,952 | D |
| Open-market purchases · 17,200 sh · avg $2.55 · $43,913 | |||||||
Loading xslF345X03/doc4.xml…